Clinical Trials

Find a Trial

Trial Summary

Protocol No.IUSCC-0624
StatusOPEN TO ACCRUAL
Principal InvestigatorLautenschlaeger, Tim
ScopeLocal
PhasePhase I/II
Age GroupAdult
TitlePhase I/II trial evaluating five fraction SABR dose escalation for early stage Squamous Cell Carcinoma of the Lung
Description
Key EligibilityIn order to be eligible to take part in this trial, patients must have:
  • Pathological diagnosis of squamous cell carcinoma of the lung
  • N0 M0 disease
For a full list of participation criteria, please visit ClinicalTrials.gov.
Applicable Disease SitesLung
Participating InstitutionsIndiana University (IU)
  • IU Health Methodist Hospital
  • Indiana University Hospital / IU Simon Cancer Center
Treatment TypeTreatment
ContactSarah Pardue, Phone:
Pager:
Email: slpardue@iu.edu